ATP
ATP HYDROLYSI
ATPASE ACTIVITY
ATPASE ACTIVITY
ATPASE ACTIVITY
ATPASE ACTIVITY
MUSCLE MYOSINII ATPASE ACTIVITY
PLATELET NM-MYOSINII S1 FRAGMENT ATPASE ACTIVITY
ABDIL
ABDIL
ACANTHAMOEBA MYOSINIC
ACANTHAMOEBA MYOSINIC
ACANTHOMOEBA
ALEXA-DYE
ANTIBODY
ANTIBODY
APLYSIA BAG CELL NEURON
APLYSIA BAG CELL NEURON SYSTEM
APLYSIA SYSTEM
ARP COMPLEX
ARP-3 LOCALIZATION
ARP2
ARP2
ARP2
ARP2
ARP2
ARP2
ARP2
ARP2
ARP3
ARP3
ARP3
ARP3
ARP3
ARP3
ARP3
ARP3
ARP3
ARP3
ARP3
ARP3
ARP3
ARP3
ARP3 IMMUNOFLUORESCENCE
ARP3 LOCALIZATION
ARP3 LOCALIZATION
ARP3 SIGNAL
ARP3-GFP
ARP3-GFP LOCALIZATION RETURN
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BUTANEDIONE MONOXIME
BDM ACTIVITY
BDM APPLICATION LEAD
BDM APPLICATION LEAD
BDM INHIBITION
BDM LEAD
BDM PHENOCOPY
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BDM TREATMENT
BS-C-1
BS-C-1 CELL
BS-C-1 CELL
BOVINE SERUM           ALBUMIN
CALBIOCHEM
COMBINING CYTOCHALASIN D
COMPOUND TREATMENT
IMMUNOFLUORESCENCE CELL COMPOUND TREATMENT
CONTROL CELLS SHOW
COVERSLIP
COVERSLIP
COVERSLIP
CYTOCHALASIN D
DIMETHYL SULFOXIDE
DIMETHYL SULFOXIDE
DMSO TREATMENT
DE-LOCALIZATION
ACTIN LEADING EDGE COMPONENT DE-LOCALIZATION
DISCUSSION BDM
EGILE
EXPERIMENTAL APPROACH
FIGURE 1B(CELLS THAT SHOWED SIGNIFICANT PERTURBATION BY THE PERMEABILIZATION PROCESS DID NOT SHOW GREATER ACTIN INCORPORATION)
FILOPODIAL EXTENSION
FLUORESCENCE LEVELS DECREASE
GFP-ARP3 GFP-ARP3 CELL
HAMMAMATSU-ORCAER
IMMUNOFLUORESCENCE CELL
JY
LIEBOVITZ L-15 MEDIUM
LISTERIA
LISTERIA
LISTERIA
LISTERIA BACTERIUM
LISTERIA BACTERIUM
LISTERIA COMET TAIL
LISTERIA EXPLOIT
LISTERIA MONOCYTOGENE
LISTERIA MONOCYTOGENE
LISTERIA MOTILITY
LOCALIZATION
ML-7 TREATMENT
METAMORPH SOFTWARE
MGCL
MOLECULAR PROBE
NA OIL EMERSION PHASE OBJECTIVE
NIKON TE300
INVERTED MICROSCOPE NIKON TE300
PHOSPHATE           BUFFERED SALINE
PHOSPHATE           BUFFERED SALINE
PLL COVERSLIP
RL
REMAINING EXPERIMENTSWERE
S. CERVISEAE
S. CERVISEAE
SANTA CRUZ SC-8432
SIGMA
TB
TBS-TX
TBS-TX
TBS-TX
TBS-TX
TL
TM
TITRATION
BUTANEDIONE MONOXIME TITRATION
TRITON X-100
TRITONX-100
VASP
VASP
VASP
VASP
VASP
VASP
VCA-ACTIVATED ARP2
WASP/WAVE FAMILY
WAVE FUNCTION
WAVE1
WAVE1
WHATMAN PAPER
ABILITY
ABSENCE
ABSENCE
COMPOUND ABSENCE
MYOSIN ABSENCE
ABSORBANCE
ACTIN
ACTIN
ACTIN
ACTIN
ACTIN
ACTIN
ACTIN
ACTIN CYTOSKELETAL RESEARCH
ACTIN CYTOSKELETON
ACTIN CYTOSKELETON
ACTIN DEPENDENT PROCESS
ACTIN DYNAMIC
ACTIN DYNAMIC
ACTIN DYNAMIC
ACTIN DYNAMIC
ACTIN DYNAMIC
ACTIN DYNAMIC
ACTIN DYNAMIC
ACTIN DYNAMIC
ACTIN DYNAMIC
ACTIN DYNAMIC
ACTIN FILAMENT FORMATION
ACTIN FILAMENT
ACTIN FILAMENT
ACTIN FILAMENT
ACTIN FILAMENT
ACTIN FILAMENT
ACTIN INCORPORATION
ACTIN INCORPORATION
ACTIN INCORPORATION
ACTIN INCORPORATION
ACTIN INCORPORATION
ACTIN LEADING EDGE
ACTIN LEADING EDGE COMPONENT
ACTIN MONOMER
ACTIN NETWORK
ACTIN NETWORK
ACTIN NUCLEATION
ACTIN NUCLEATION
ACTIN NUCLEATION
ACTIN NUCLEATION
ACTIN NUCLEATION ARP2
ACTIN POLYMERIZATION
ACTIN POLYMERIZATION
ACTIN POLYMERIZATION
ACTIN POLYMERIZATION
ACTIN POLYMERIZATION
ACTIN POLYMERIZATION
ACTIN POLYMERIZATION MACHINERY
ACTIN-DEPENDENT PROCESS
ADDITION
AFFECTING ACTIN DYNAMIC
AFFINITY
ANTIBIOTIC-FREE MEDIUM
ASPECT
ACTIN CYTOSKELETAL RESEARCH ASPECT
ASSAY
ASSISTED LASER INACTIVATION SAW
BINDING PARTNER
BIOLOGICAL PROCESS
BIOLOGICAL PROCESS
BIOLOGICAL PROCESS
BLEBBISTATIN
BLEBBISTATIN
BLOCKED INCORPORATION
CAUSAL RELATIONSHIP
CELL ASSAY
CELL ASSAY
CELL MOTILITY
CENTRIPETAL FLOW
ACTIN CENTRIPETAL FLOW
CHICKEN MYOSINV
CHROMOPHORE
ASSISTED LASER INACTIVATION SAW CHROMOPHORE
COATED COVERSLIP
COELOMYOCTE SYSTEM
COLLABORATION
COMPLEX DE-LOCALIZATION
COMPLEX LOCALIZATION
COMPOUND
COMPOUND
COMPOUND
COMPOUND
CONCENTRATION
CONCENTRATION
CONCOMITANT ARP3 DE-LOCALIZATION
CONSTANT DMSO CONCENTRATION
CONTINUED ACTIN POLYMERIZATION
CONTINUED CONTRACTION
ACTIN NETWORK CONTINUED CONTRACTION
CONTRIBUTION
JY CONTRIBUTION
CONTROL CELL
CONTROLLING ACTIN DYNAMIC
COVERSLIP
CYTOCHALASIN D
CYTOCHALASIN D
CYTOCHALASIN D
CYTOCHALASIN D
CYTOCHALASIN D
CYTOCHALASIN D
CYTOCHALASIN D
CYTOCHALASIN D
CYTOSKELETAL NETWORK
CYTOSKELETON
CYTOSKELETON
DE-LOCALIZATION
DE-LOCALIZATION
DE-LOCALIZATION
DE-LOCALIZATION
DE-LOCALIZATION
DE-LOCALIZATION
ARP2 DE-LOCALIZATION
ARP3 DE-LOCALIZATION
DE-LOCALIZED
DE-LOCALIZED
DECREASE INCORPORATION
EXOGENOUS ACTIN DECREASE INCORPORATION
DENDRITIC NETWORK
DETAILED DESCRIPTION
DETERGENT SAPONIN
DILUTED CONCENTRATION
DISCREPANCY
DISSOCIATION
DISSOCIATION
DORSAL ROOT GANGLIA NEURON
DRUG TREATMENT
ESTABLISHMENT
EXOGENOUS ACTIN
EXOGENOUS ACTIN
EXOGENOUS ACTIN
EXPRESSING ARP3-GFP
FETAL CALF SERUM
FILAMENT ELONGATION
FILAMENT FORMATION
FILAMENT NUCLEATION
FILOPODIA
FILOPODIA
FILOPODIA
FILOPODIA-LIKE PROJECTION
FILOPODIAL EXTENSION
FILOPODIAL PRECURSOR
FINAL MANUSCRIPT
FIXED
FIXED
FIXED
FIXED
IMMUNOFLOURESCENCE FIXED
FLOW CHAMBER
FLOW RATE
FLOW STUDY
FLUORESCENCE INCORPORATION
FLUORESCENCE INTENSITY
FLUORESCENCE LEVEL
FLUORESCENCE SIGNAL
FORMALDEHYDE
FORMALDEHYDE
G/ML
SAPONIN G/ML
GLYCEROL
GOAT ANTI-MOUSE
GOAT ANTI-RABBIT
GROWING END
GROWING END
ACTIN FILAMENT GROWING END
ACTIN FILAMENT GROWING END
GROWTH CONE
GROWTH CONE
GROWTH CONE INTERIOR
HEAT BLOCK
HELP ADDRESS
HR
HR
HR
HUMAN MYOIE
HUMAN MYOIE
HUMAN PLATELET NM-MYOSINII
IMMUNOFLOURESCENCE
IMMUNOFLUORESCENCE CELL
IN VITRO ATPASE ACTIVITY
HUMAN PLATELET NM-MYOSINII IN VITRO ATPASE ACTIVITY
IN VITRO ACTIN ASSEMBLY
IN VITRO FILOPODIA FORMATION
INCORPORATION
INCORPORATION
EXOGENOUS ACTIN INCORPORATION
INFECTED CELL STOP
INHIBITING NM-MYOSINII
INHIBITING NON-MUSCLE MYOSINII
INTERACTION
INTERESTING DIFFERENCE
INTERPRETATION
INVERTED MICROSCOPE
JASPLAKINOLIDE
JASPLAKINOLIDE
KNOW
LABELED ACTIN
LATRUNCULIN
LATRUNCULIN
LEADING EDGE ACTIN
LEADING EDGE ACTIN NETWORK
LINESCAN
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
LOCALIZATION
ARP3 LOCALIZATION
ARP3 LOCALIZATION
ARP3 LOCALIZATION
VASP LOCALIZATION
MM ATP
MM BDM
MM BDM
MM BDM
MM BDM
MM BDM
MM BDM
MM DTT
MM EGTA
MM ETGA
MM HEPE
MM K-PIPES PH
MM KCL
MM MGCL2
MM TRIS-PH
MM UREA
MAMMALIAN CELL
MAMMALIAN CELL
BUTANEDIONE MONOXIME MAMMALIAN CELL
MEDIATED PROCESS
MILLIMOLAR INHIBITOR
MULTIPLE NON-MUSCLE MYOSIN MILLIMOLAR INHIBITOR
MILLIMOLAR RANGE
MIN
MIN
MIN
MIN
MIN EPPENDORF CENTRIFUGE SPIN
BDM TREATMENT MIN
ML
MM PLL
COATED COVERSLIP MM PLL
MM POLY-L-LYSINE
MOLECULE
MOLECULE
MOLECULE APPROACH
MORPHOLOGICAL CHANGE
MOTOR PROTEIN
MOUSE ACTIN ANTIBODY
M
MULTIPLE CELL TYPE
MULTIPLE NON-MUSCLE MYOSIN
MUSCLE MYOSINII
MYOSIN
MYOSIN ATPASE EXPERIMENT
MYOSIN S1 MICROINJECTION
MYOSIN ACTIVITY
MYOSIN ACTIVITY
MYOSIN FUNCTION
MYOSIN MOTOR PROTEIN
MYOSIN TARGET
MYOSIN
MYOSIN
PULLING FILAMENT MYOSIN
MYSOSIN
NM
NEGATIVE NM-MYOSINII
NM
NM-MYOSINII
NM-MYOSINII
NM-MYOSINII
NM-MYOSINII
NM-MYOSINII
NM-MYOSINII
NM-MYOSINII ATPASE ACTIVITY
NM-MYOSIN
NON-MUSCLE MYOSINII
NON-MUSCLE MYOSIN
NUCLEATION
NUCLEATION
NUCLEATION
NUCLEATION
NUCLEATION ACTIVITY
ARP2 NUCLEATION ACTIVITY
NUCLEATION COMPLEX
ONE-MINUTE TREATMENT
ORGANIZATION
OTHER ACTIN
MEDIATED PROCESS OTHER ACTIN
P-PHENYLENEDIAMINE
PH
PELLETING
PEPTIDE
PERMEABILIZATION
PERMEABILIZATION
PERMEABILIZATION
PERMEABILIZATION BUFFER
PERMEABILIZATION PROCESS
PERMEABILIZATION/FIXATION BUFFER
PERSONAL COMMUNICATION
PLATELET NM-MYOSINII S1 FRAGMENT
POLYMERIZATION
POLYMERIZATION
POLYMERIZATION
POLYMERIZATION
POLYMERIZATION
ACTIN POLYMERIZATION
ACTIN POLYMERIZATION
PORCINE MYOSINVI
POSSIBLE MECHANISM
ARP2 POSSIBLE MECHANISM
POSSIBLE OSMOTIC EFFECT
BDM TREATMENT POSSIBLE OSMOTIC EFFECT
PROBE ACTIN-DEPENDENT PROCESS
PROTEASE INHIBITOR
PROTEIN
PULLING FILAMENT
PUSH-PULL
PYRENE-ACTIN POLYMERIZATION ASSAY
RABBIT ARP3 ANTIBODY
RABBIT VASP ANTIBODY
RABBIT WAVE1 ANTIBODY
RABBIT MUSCLE MYOSINII
READOUT
RELATIONSHIP
ACTIN DYNAMIC RELATIONSHIP
REORGANIZATION
DENDRITIC NETWORK REORGANIZATION
RESUSPENDING
ROOM TEMP
SAPONIN
SEA URCHIN COELOMOCYTE
SEA URCHIN COELOMOCYTE
SECONDARY ANTIBODY
SECONDARY ANTIBODY
SENSITIVE STRUCTURE
SHOW DATA
SHOWED LOCALIZATION
ARP3 SHOWED LOCALIZATION
SPREAD BS-C-1 CELL
STAINING ACTIN NETWORK
STOCK SOLUTION
STUDY NM-MYOSINII FUNCTION
SUBUNIT
ACTIN NUCLEATION ARP2 SUBUNIT
TEMPORAL CONTROL
FILAMENT NUCLEATION TEMPORAL CONTROL
TEMPORARY INHIBITION
TIME SHOW
TIME-LAPSE EXPERIMENT
TIME-LAPSE MICROSCOPY
UM
UM BLEBBISTATIN
UM CYTOCHALASIN D
UM CYTOCHALASIN D
UM RHODAMINE ACTIN
UG/ML GENTAMICIN
UL
UL
LISTERIA UL
WARMED SAMPLE SOLUTION UL
UN-DESCRIBED EFFECT
BDM TREATMENT UN-DESCRIBED EFFECT
UNDERSTANDING CELL
BIOLOGICAL PROCESS UNDERSTANDING CELL
WARMED SAMPLE SOLUTION
WICKING
BUTANEDIONE MONOXIME
BDM
PURINE NUCLEOSIDE PHOSPHORYLASE
PNP
ATPASE
ATPASE
ATPASE
ATPASE
MYOSINIC
MYOSINIC
APLYSIA
BAG CELL NEURON
CELL NEURON
APLYSIA BAG CELL NEURON
APLYSIA
neurons
APLYSIA
LOCALIZATION
ARP3
immunofluorescence
ARP3
LOCALIZATION
ARP3
LOCALIZATION
ARP3
signals
ARP3-GFP LOCALIZATION
BDM APPLICATION
BDM APPLICATION
inhibition
treatments
treatments
treatments
treatments
treatments
treatments
treatments
treatments
treatments
treatments
treatments
treatments
treatments
treatments
treatments
CONTROL
CELLS SHOW
treatments
BDM
FILOPODIAL
extensions
LEVELS DECREASE
IMMUNOFLUORESCENCE
LISTERIA
LISTERIA
LISTERIA
LISTERIA
exploit
LISTERIA
LISTERIA
LISTERIA
motility
treatments
OIL EMERSION PHASE OBJECTIVE
EMERSION PHASE OBJECTIVE
TE300
EXPERIMENTSWERE
CERVISEAE
CERVISEAE
TRITON
ARP2
functions
papers
ACTIN
CYTOSKELETAL RESEARCH
CYTOSKELETAL
ACTIN
CYTOSKELETON
ACTIN
CYTOSKELETON
ACTIN
ACTIN
ACTIN
ACTIN
ACTIN
ACTIN
ACTIN
ACTIN
ACTIN
ACTIN
ACTIN
ACTIN
FILAMENT FORMATION
ACTIN
ACTIN
ACTIN
ACTIN
ACTIN
ACTIN
INCORPORATION
ACTIN
INCORPORATION
ACTIN
INCORPORATION
ACTIN
INCORPORATION
ACTIN
INCORPORATION
ACTIN
LEADING EDGE
ACTIN LEADING EDGE
ACTIN
ACTIN
ACTIN
ACTIN
ACTIN
NUCLEATION
ACTIN
NUCLEATION
ACTIN
NUCLEATION
ACTIN
NUCLEATION
ACTIN NUCLEATION
ACTIN
NUCLEATION ARP2
NUCLEATION
ACTIN
POLYMERIZATION
ACTIN
POLYMERIZATION
ACTIN
POLYMERIZATION
ACTIN
POLYMERIZATION
ACTIN
POLYMERIZATION
ACTIN
POLYMERIZATION
ACTIN POLYMERIZATION
ACTIN
POLYMERIZATION MACHINERY
POLYMERIZATION
ACTIN-DEPENDENT
AFFECTING ACTIN
ACTIN
inactivation
INCORPORATION
RELATIONSHIP
motility
FLOW
MYOSINV
DE-LOCALIZATION
LOCALIZATION
ARP3 DE-LOCALIZATION
ARP3
DMSO CONCENTRATION
DMSO
ACTIN POLYMERIZATION
ACTIN
contraction
CONTROL
CONTROLLING ACTIN
ACTIN
CYTOSKELETAL
decreases
INCORPORATION
detergent
SAPONIN
dorsal root
drugs
treatments
ACTIN
ACTIN
ACTIN
ELONGATION
FORMATION
NUCLEATION
FILOPODIA-LIKE
FILOPODIAL
extensions
FILOPODIAL
FLOW
FLOW
FLOW
INCORPORATION
signals
anti-mouse
anti-rabbit
growth
growth
growth
ADDRESS
MYOIE
MYOIE
platelets
IMMUNOFLUORESCENCE
NON-MUSCLE MYOSINII
NON-MUSCLE
differences
ACTIN
LEADING EDGE
EDGE ACTIN
LEADING EDGE ACTIN
LEADING EDGE
ACTIN
ATP
BDM
BDM
BDM
BDM
BDM
BDM
DTT
EGTA
ETGA
K-PIPES PH
KCL
MGCL2
urea
mammalian
mammalian
MILLIMOLAR
inhibitors
MILLIMOLAR
ranges
MIN
PLL
approaches
changes
MOUSE ACTIN
ACTIN
MULTIPLE
MULTIPLE NON-MUSCLE
MULTIPLE
NON-MUSCLE
MYOSINII
MYOSIN ATPASE
MYOSIN
ATPASE
MYOSIN
S1 MICROINJECTION
S1
MYOSIN
MYOSIN
MYOSIN
functions
MYOSIN
MYOSIN
targets
ATPASE
NON-MUSCLE
MYOSINII
NON-MUSCLE
NUCLEATION
NUCLEATION
treatments
ACTIN
PERMEABILIZATION
buffer
PERMEABILIZATION
buffer
communication
platelets
S1
MYOSINVI
POSSIBLE OSMOTIC
OSMOTIC
PROBE ACTIN-DEPENDENT
probes
ACTIN-DEPENDENT
proteases
POLYMERIZATION
RABBIT ARP3
ARP3
RABBIT VASP
VASP
RABBIT WAVE1
WAVE1
MUSCLE MYOSINII
SEA
URCHIN COELOMOCYTE
SEA
shows
LOCALIZATION
SPREAD BS-C-1
BS-C-1
ACTIN
stocks
solution
studies
NM-MYOSINII FUNCTION
CONTROL
inhibition
times
EXPERIMENTS
UM
BLEBBISTATIN
UM
UM
UM
RHODAMINE ACTIN
rhodamine
ug/ml
GENTAMICIN
effects
sample solution
